Search Results
Abstracts
PK and safety of F/TAF with boosted 3rd agents in children with HIV
E. Castaño
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIV
N. Rakhmanina
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Safety and efficacy of E/C/F/TAF in virologically suppressed, HIV-infected children through 96 Weeks
Presented at:
International Workshop on HIV & Pediatrics 2019
Slidesets
Weighty Matters in HIV Treatment 2021 - Clinical Case Presentation 2 - Focus on Women - Grace McComsey
Presented at:
Weighty Matters in HIV Treatment 2021
Slidesets
Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and CD4+ T Lymphocyte Depletion in Treated HIV Infection | Dr. J. Lake
Presented at:
International Workshop on HIV & Aging 2016
Slidesets
Anita Suleiman, MD, MPH, FAMM - Success Story 1
Presented at:
Asian Stigma & Discrimination Forum 2023
Slidesets
Outcome of HCV treatment by direct acting antiretroviral (DAAs) among HCV/HIV co-infections in Vietnam- Thu Nguyen
Presented at:
APACC 2018
Slidesets
Living donor liver transplantation for hepatitis virus related liver diseases- Chao-Long Chen, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Future Possible Parenting Identity and Relationship Goals as They Intersect with Gender... - Jenifer K. McGuire
Presented at:
International Workshop on HIV and Transgender People 2021